Regulation of FGF-2 by an endogenous antisense RNA: Effects on cell adhesion and cell-cycle progression

Molecular Carcinogenesis

Volumn 49, Issue 12, 2010, Pages 1031-1044

  MacFarlane, Leigh Ann ^a   Murphy, Paul R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cell adhesion; Cell cycle Proliferation; Fibroblast growth factor 2; Natural antisense

Indexed keywords

COMPLEMENTARY RNA; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 27; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCT; INITIATION FACTOR 4 BINDING PROTEIN 2; PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; SESTRIN 3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL INVASION; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

ADENOCARCINOMA; APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEINS; RNA, SMALL INTERFERING;

EID: 78649514483     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20686     Document Type: Article

References (88)

1. Sonoda G, Palazzo J, du Manoir S, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997; 20: 320-328.
2. Chou YH, Chung KC, Jeng LB, Chen TC, Liaw YF. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett 1998; 123: 1-6.
3. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet Cytogenet 1999; 110: 87-93.
4. Shlomit R, Ayala AG, Michal D, et al. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 2000; 121: 67-72.
5. Rigaud G, Moore PS, Zamboni G, et al. Allelotype of pancreatic acinar cell carcinoma. Int J Cancer 2000; 88: 772-777.
6. Rumpel CA, Powell SM, Moskaluk CA. Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas. Am J Pathol 1999; 154: 1329-1334.
7. Barnas CHT, Stark M, Haas O, et al. Detection of genetic alterations in cancers of the esophagus and esophagogastric junction by comparative genomic hybridization: Frequent involvement of chromosome 4q. Proc Am Assoc Cancer Res 1999; 1: 539.
8. Asa SL, Ramyar L, Murphy PR, Li AW, Ezzat S. The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production. Mol Endocrinol 2001; 15: 589-599.
9. Fukushima Y, Byers MG, Fiddes JC, Shows TB. The human basic fibroblast growth factor gene (FGFB) is assigned to chromosome 4q25. Cytogenet Cell Genet 1990; 54: 159-160.
10. Barclay C, Li AW, Geldenhuys L, et al. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin Cancer Res 2005; 11: 7683-7691.
11. Demou ZN, Hendrix MJ. Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J Cell Biochem 2008; 105: 562-573.
12. Giri D, Ropiquet F, Ittmann M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 1999; 5: 1063-1071.
13. Pardo OE, Wellbrock C, Khanzada UK, et al. FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. EMBO J 2006; 25: 3078-3088.
14. Zhang SC, Barclay C, Alexander LA, et al. Alternative splicing of the FGF antisense gene: Differential subcellular localization in human tissues and esophageal adenocarcinoma. J Mol Med 2007; 85: 1215-1228.
15. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
16. Baguma-Nibasheka M, Li AW, Murphy PR. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol Cell Endocrinol 2007; 267: 127-136.
17. Baguma-Nibasheka M, Li AW, Osman MS, et al. Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells. Leuk Res 2005; 29: 423-433.
18. Knee R, Li AW, Murphy PR. Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein. Proc Natl Acad Sci USA 1997; 94: 4943-4947.
19. Li AW, Murphy PR. Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: Regulation of FGF-2 mRNA translation. Mol Cell Endocrinol 2000; 170: 233-242.
20. Murphy PR, Knee RS. Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene. Mol Endocrinol 1994; 8: 852-859.
21. Li AW, Seyoum G, Shiu RP, Murphy PR. Expression of the rat BFGF antisense RNA transcript is tissue-specific and developmentally regulated. Mol Cell Endocrinol 1996; 118: 113-123.
22. Gagnon ML, Moy GK, Klagsbrun M. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells. J Cell Biochem 1999; 72: 492-506.
23. Grothe C, Meisinger C. Fibroblast growth factor (FGF)-2 sense and antisense mRNA and FGF receptor type 1 mRNA are present in the embryonic and adult rat nervous system: Specific detection by nuclease protection assay. Neurosci Lett 1995; 197: 175-178.
24. Zuniga Mejia, Borja A, Meijers C, Zeller R. Expression of alternatively spliced bFGF first coding exons and antisense mRNAs during chicken embryogenesis. Dev Biol 1993; 157: 110-118.
25. Sukhthankar M, Choi CK, English A, Kim JS, Baek SJ. A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level. J Nutr Biochem 2009; 21: 98-106.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
27. MacFarlane L, Gu Y, Casson AG, Murphy PR. Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2. Mol Endocrinol 2010; 24: 800-812.
28. Dennis G, Jr., Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
29. Hosack DA, Dennis G, Jr., Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
30. Kobayashi N, Yang J, Ueda A, et al. RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene 2007; 396: 236-247.
31. Nayal A, Webb DJ, Horwitz AF. Talin: An emerging focal point of adhesion dynamics. Curr Opin Cell Biol 2004; 16: 94-98.
32. Nelissen JM, Peters IM, de Grooth BG, van Kooyk Y, Figdor CG. Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton. Mol Biol Cell 2000; 11: 2057-2068.
33. Rabenau KE, O'Toole JM, Bassi R, et al. DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene 2004; 23: 5056-5067.
34. Gassmann P, Enns A, Haier J. Role of tumor cell adhesion and migration in organ-specific metastasis formation. Onkologie 2004; 27: 577-582.
35. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 1996; 93: 4350-4354.
36. Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 2004; 18: 2602-2607.
37. Su L, Pertz O, Mikawa M, Hahn K, Parsons SJ. p190RhoGAP negatively regulates Rho activity at the cleavage furrow of mitotic cells. Exp Cell Res 2009; 315: 1347-1359.
38. Topper LM, Campbell MS, Tugendreich S, et al. The dephosphorylated form of the anaphase-promoting complex protein Cdc27/Apc3 concentrates on kinetochores and chromosome arms in mitosis. Cell Cycle 2002; 1: 282-292.
39. Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008; 134: 451-460.
40. Clemens MJ. Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins. J Cell Mol Med 2001; 5: 221-239.
41. Cormier P, Pyronnet S, Salaun P, Mulner-Lorillon O, Sonenberg N. Cap-dependent translation and control of the cell cycle. Prog Cell Cycle Res 2003; 5: 469-475.
42. Fletcher CM, McGuire AM, Gingras AC, et al. 4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry 1998; 37: 9-15.
43. Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 2007; 67: 4671-4678.
44. Ridley AJ, Self AJ, Kasmi F, et al. rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo. EMBO J 1993; 12: 5151-5160.
45. Takai Y, Kaibuchi K, Sasaki T, Tanaka K, Shirataki H, Nakanishi H. Rho small G protein and cytoskeletal control. Princess Takamatsu Symp 1994; 24: 338-350.
46. Wildenberg GA, Dohn MR, Carnahan RH, et al. p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell 2006; 127: 1027-1039.
47. Klein EA, Yung Y, Castagnino P, Kothapalli D, Assoian RK. Cell adhesion, cellular tension, and cell cycle control. Methods Enzymol 2007; 426: 155-175.
48. Bouche G, Baldin V, Belenguer P, Prats H, Amalric F. Activation of rDNA transcription by FGF-2: Key role of protein kinase CKII. Cell Mol Biol Res 1994; 40: 547-554.
49. Kimelman D, Kirschner MW. An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell 1989; 59: 687-696.
50. Knee RS, Pitcher SE, Murphy PR. Basic fibroblast growth factor sense (FGF) and antisense (gfg) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem Biophys Res Commun 1994; 205: 577-583.
51. Conne B, Stutz A, Vassalli JD. The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 2000; 6: 637-641.
52. Grzybowska EA, Wilczynska A, Siedlecki JA. Regulatory functions of 3'UTRs. Biochem Biophys Res Commun 2001; 288: 291-295.
53. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
54. Newbury SF. Control of mRNA stability in eukaryotes. Biochem Soc Trans 2006; 34: 30-34.
55. Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 2003; 34: 157-165.
56. Wang Y, Joh K, Masuko S, et al. The mouse Murr1 gene is imprinted in the adult brain, presumably due to transcriptional interference by the antisense-oriented U2af1-rs1 gene. Mol Cell Biol 2004; 24: 270-279.
57. Zhang Z, Carmichael GG. The fate of dsRNA in the nucleus: A p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001; 106: 465-475.
58. Enerly E, Sheng Z, Li KB. Natural antisense as potential regulator of alternative initiation, splicing and termination. In Silico Biol 2005; 5: 367-377.
59. Hastings ML, Ingle HA, Lazar MA, Munroe SH. Post-transcriptional regulation of thyroid hormone receptor expression by cis-acting sequences and a naturally occurring antisense RNA. J Biol Chem 2000; 275: 11507-11513.
60. Hannon GJ. RNA interference. Nature 2002; 418: 244-251.
61. Pugacheva EN, Roegiers F, Golemis EA. Interdependence of cell attachment and cell cycle signaling. Curr Opin Cell Biol 2006; 18: 507-515.
62. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077-2086.
63. Reed SI. Control of the G1/S transition. Cancer Surv 1997; 29: 7-23.
64. Su L, Agati JM. Parsons SJ. p190RhoGAP is cell cycle regulated and affects cytokinesis. J Cell Biol 2003; 163: 571-582.
65. Velasco-Miguel S, Buckbinder L, Jean P, et al. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 1999; 18: 127-137.
66. Cao Q, Kim JH, Richter JD. CDK1 and calcineurin regulate Maskin association with eIF4E and translational control of cell cycle progression. Nat Struct Mol Biol 2006; 13: 1128-1134.
67. Rousseau D, Gingras AC, Pause A, Sonenberg N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996; 13: 2415-2420.
68. Lee JG, Kay EP. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. Invest Ophthalmol Vis Sci 2008; 49: 189-196.
69. Lemiere S, Azar R, Belloc F, et al. Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation. Exp Cell Res 2008; 314: 3701-3711.
70. Heesom KJ, Gampel A, Mellor H, Denton RM. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr Biol 2001; 11: 1374-1379.
71. Pyronnet S, Dostie J, Sonenberg N. Suppression of cap-dependent translation in mitosis. Genes Dev 2001; 15: 2083-2093.
72. Pyronnet S, Sonenberg N. Cell-cycle-dependent translational control. Curr Opin Genet Dev 2001; 11: 13-18.
73. Hirst CJ, Herlyn M, Cattini PA, Kardami E. High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death. Mol Cell Biochem 2003; 246: 111-116.
74. Maloof P, Wang Q, Wang H, et al. Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1999; 56: 153-167.
75. Wadehra M, Natarajan S, Seligson DB, et al. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer 2006; 107: 90-98.
76. Zheng R, Yano S, Zhang H, et al. CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice. Oncol Res 2005; 15: 365-372.
77. Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma: Increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008; 17: 1363-1372.
78. Potter N, Karakoula A, Phipps KP, et al. Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma. Neoplasia (New York, NY) 2008; 10: 757-772.
79. Geismann C, Morscheck M, Koch D, et al. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: Role in malignant transformation of pancreatic cancer. Cancer research 2009; 69: 4517-4526.
80. Wiesner C, Nabha SM, Dos Santos EB, et al. C-kit and its ligand stem cell factor: Potential contribution to prostate cancer bone metastasis. Neoplasia (New York, NY) 2008; 10: 996-1003.
81. Zhang W, Stoica G, Tasca SI, Kelly KA, Meininger CJ. Modulation of tumor angiogenesis by stem cell factor. Cancer research 2000; 60: 6757-6762.
82. Emberley ED, Gietz RD, Campbell JD, HayGlass KT, Murphy LC, Watson PH. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2002; 2: 28.
83. Wang D, Li Z, Messing EM, Wu G. Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J Biol Chem 2002; 277: 36216-36222.
84. Wang DZ, Nur EKMS, Tikoo A, Montague W, Maruta H. The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120, 000 Ras GAP, independently function as anti-Ras tumor suppressors. Cancer research 1997; 57: 2478-2484.
85. Kusama T, Mukai M, Endo H, et al. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis. Cancer Sci 2006; 97: 848-853.
86. Chakravarty G, Roy D, Gonzales M, Gay J, Contreras A, Rosen JM. P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer. Cell Growth Differ 2000; 11: 343-354.
87. Kuzbicki L, Gajo B, Chwirot BW. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions. Melanoma Res 2006; 16: 235-243.
88. Flynn A, Proud CG. The role of eIF4 in cell proliferation. Cancer Surv 1996; 27: 293-310.